VGLL4 Antikörper (AA 136-163)
Kurzübersicht für VGLL4 Antikörper (AA 136-163) (ABIN1881992)
Target
Alle VGLL4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 136-163
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This VGLL4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 136-163 amino acids from the Central region of human VGLL4.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Haltbarkeit
- 6 months
-
-
-
: "Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. ..." in: Gut, Vol. 58, Issue 8, pp. 1078-83, (2009) (PubMed).
: "Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes." in: The Journal of biological chemistry, Vol. 279, Issue 29, pp. 30800-6, (2004) (PubMed).
-
-
- VGLL4 (Vestigial Like 4 (VGLL4))
-
Andere Bezeichnung
- VGLL4
-
Hintergrund
- VGLL4 may act as a specific coactivator for the mammalian TEFs (By similarity).
-
Molekulargewicht
- 30948
-
NCBI Accession
- NP_001121691, NP_001121692, NP_001121693, NP_055482
-
UniProt
- Q14135
Target
-